Lipoxygenase: An Emerging Target for Stroke Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|12|2|191-199

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.12, Iss.2, 2013-04, pp. : 191-199

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Anti-inflammatory Interleukin-35 as an Emerging Target for Antiatherosclerotic Therapy

By  

Current Pharmaceutical Design, Vol. 21, Iss. 9, 2015-03 ,pp. : 1147-1151

Bentham Science Publishers

Access to resources Recommend Favorite

Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 9, Iss. 8, 2009-12 ,pp. : 938-952

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in the Identification of Stroke-Related Genes: Emerging New Possibilities to Develop Concepts in Stroke Therapy

By Lippoldt Andrea  

CNS Drugs, Vol. 19, Iss. 10, 2005-01 ,pp. : 821-832

Adis International

Access to resources Recommend Favorite

Prostate apoptosis response-4 (Par-4): an emerging target for Alzheimer’s and Parkinson’s diseases and stroke

By Mattson M.P.  

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 1, 2000-02 ,pp. : 51-63

Informa Healthcare

Access to resources Recommend Favorite

Emerging treatments for stroke in humans

By Koroshetz W.J.   Moskowitz M.A.  

Trends in Pharmacological Sciences, Vol. 17, Iss. 6, 1996-06 ,pp. : 227-233

Elsevier

Access to resources Recommend Favorite